Clinical toxicology (Philadelphia, Pa.) · 2026
In vitro studies of detoxification by intravenous fat emulsions: mechanism of action and preclinical assessment tools.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Krastev Delyan, Atanasov Vasil, Vinarov Zahari, Tcholakova Slavka, Denkov Nikolai
Аннотация
INTRODUCTION: The use of intravenous fat emulsions for treatment of drug intoxication still follows a trial-and-error approach, due to insufficient understanding of the mechanisms of the process and lack of predictive in vitro tools.
METHODS: We studied the physicochemical mechanisms of drug extraction from model plasma for seven drugs (bromazepam, bupivacaine, diphenhydramine, mepivacaine, quetiapine, paracetamol and verapamil) with clinical data for the detoxification efficiency of intravenous fat emulsions. Five of the studied drugs were labeled as "responders," due to clinical reports of successful patient detoxification, whereas the other two drugs were "non-responders," as they did not respond to intravenous fat emulsion treatment.
RESULTS: For all responders, drug extraction increased significantly with the increase of emulsion concentration, while the drug partition coefficient between model plasma and intravenous fat emulsion (Intralipid®) remained around or above 10: viz. the concentration of drug in the lipid phase was ten‑fold higher than in its concentration in the model plasma.
DISCUSSION: Drug partitioning from the model plasma to the bulk of the emulsion oil droplets was identified as the primary scavenging mechanism, whereas adsorption on the oil-water interface did not influence the process. For the studied seven drugs, it was established that a threshold value of 10 of the drug partition coefficient between model plasma and intravenous lipid emulsion can be successfully used to discriminate between drugs for which intravenous fat emulsions can lead to partitioning, indicating potential clinical efficiency in detoxification.
CONCLUSION: The approach described can be used to guide clinical practice in drug intoxication cases where a specific antidote is not available, expanding the treatment options of patients in intensive care conditions.
METHODS: We studied the physicochemical mechanisms of drug extraction from model plasma for seven drugs (bromazepam, bupivacaine, diphenhydramine, mepivacaine, quetiapine, paracetamol and verapamil) with clinical data for the detoxification efficiency of intravenous fat emulsions. Five of the studied drugs were labeled as "responders," due to clinical reports of successful patient detoxification, whereas the other two drugs were "non-responders," as they did not respond to intravenous fat emulsion treatment.
RESULTS: For all responders, drug extraction increased significantly with the increase of emulsion concentration, while the drug partition coefficient between model plasma and intravenous fat emulsion (Intralipid®) remained around or above 10: viz. the concentration of drug in the lipid phase was ten‑fold higher than in its concentration in the model plasma.
DISCUSSION: Drug partitioning from the model plasma to the bulk of the emulsion oil droplets was identified as the primary scavenging mechanism, whereas adsorption on the oil-water interface did not influence the process. For the studied seven drugs, it was established that a threshold value of 10 of the drug partition coefficient between model plasma and intravenous lipid emulsion can be successfully used to discriminate between drugs for which intravenous fat emulsions can lead to partitioning, indicating potential clinical efficiency in detoxification.
CONCLUSION: The approach described can be used to guide clinical practice in drug intoxication cases where a specific antidote is not available, expanding the treatment options of patients in intensive care conditions.